{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T11:58:32Z","timestamp":1746187112356},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,29]]},"DOI":"10.7759\/cureus.29764","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T03:29:16Z","timestamp":1664508556000},"source":"Crossref","is-referenced-by-count":4,"title":["Daptomycin-Related Rhabdomyolysis Complicated by Severe Hyperkalemia and Acute Kidney Injury"],"prefix":"10.7759","author":[{"given":"Yoshito","family":"Nishimura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr398","article-title":"Rhabdomyolysis associated with the co-administration of daptomycin and pegylated interferon \u03b1-2b and ribavirin in a patient with hepatitis C","volume":"67","author":"Colomba C","year":"2012","unstructured":"Colomba C, Rubino R, Siracusa L, Mazzola G, Titone L. Rhabdomyolysis associated with the co-administration of daptomycin and pegylated interferon \u03b1-2b and ribavirin in a patient with hepatitis C. J Antimicrob Chemother. 2012, 67:249-50. 10.1093\/jac\/dkr398","journal-title":"J Antimicrob Chemother"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp127","article-title":"Rhabdomyolysis and acute renal failure associated with the co-administration of daptomycin and an HMG-CoA reductase inhibitor","volume":"63","author":"Odero RO","year":"2009","unstructured":"Odero RO, Cleveland KO, Gelfand MS. Rhabdomyolysis and acute renal failure associated with the co-administration of daptomycin and an HMG-CoA reductase inhibitor. J Antimicrob Chemother. 2009, 63:1299-300. 10.1093\/jac\/dkp127","journal-title":"J Antimicrob Chemother"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000109868","article-title":"Daptomycin: a review 4 years after first approval","volume":"81","author":"Sauermann R","year":"2008","unstructured":"Sauermann R, Rothenburger M, Graninger W, Joukhadar C. Daptomycin: a review 4 years after first approval. Pharmacology. 2008, 81:79-91. 10.1159\/000109868","journal-title":"Pharmacology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2014.901555","article-title":"Daptomycin-induced rhabdomyolysis and acute liver injury","volume":"46","author":"King ST","year":"2014","unstructured":"King ST, Walker ED, Cannon CG, Finley RW. Daptomycin-induced rhabdomyolysis and acute liver injury. Scand J Infect Dis. 2014, 46:537-40. 10.3109\/00365548.2014.901555","journal-title":"Scand J Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.regg.2018.05.008","article-title":"Early onset rhabdomyolysis and acute renal failure associated with the administration of daptomycin. A Case report and literature review (Article in Spanish)","volume":"53","author":"Ram\u00edrez-Mart\u00edn R","year":"2018","unstructured":"Ram\u00edrez-Mart\u00edn R, P\u00e9rez-Rodr\u00edguez P, Rico-Nieto A, Maule\u00f3n-Ladrero C. Early onset rhabdomyolysis and acute renal failure associated with the administration of daptomycin. A Case report and literature review (Article in Spanish). Rev Esp Geriatr Gerontol. 2018, 53:362-3. 10.1016\/j.regg.2018.05.008","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/504379","article-title":"Rhabdomyolysis during therapy with daptomycin","volume":"42","author":"Papadopoulos S","year":"2006","unstructured":"Papadopoulos S, Ball AM, Liewer SE, Martin CA, Winstead PS, Murphy BS. Rhabdomyolysis during therapy with daptomycin. Clin Infect Dis. 2006, 42:e108-10. 10.1086\/504379","journal-title":"Clin Infect Dis"},{"key":"ref7","article-title":"Daptomycin and incidence of elevated creatinine phosphokinase (CPK) levels: a case report and case series review","volume":"72","author":"Kishimoto E","year":"2013","unstructured":"Kishimoto E, Ota L, Solomon C. Daptomycin and incidence of elevated creatinine phosphokinase (CPK) levels: a case report and case series review. Hawaii J Med Public Health. 2013, 72:42.","journal-title":"Hawaii J Med Public Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.10.010320","article-title":"G20 Okayama Health Ministers' Meeting: conclusions and commitments","volume":"10","author":"Nishizawa H","year":"2020","unstructured":"Nishizawa H, Nishimura Y, Matsumura H, et al.. G20 Okayama Health Ministers' Meeting: conclusions and commitments. J Glob Health. 2020, 10:010320. 10.7189\/jogh.10.010320","journal-title":"J Glob Health"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/113477-daptomycin-related-rhabdomyolysis-complicated-by-severe-hyperkalemia-and-acute-kidney-injury","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:18Z","timestamp":1707507618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/113477-daptomycin-related-rhabdomyolysis-complicated-by-severe-hyperkalemia-and-acute-kidney-injury"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.29764","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,29]]}}}